Cargando…
Visceral adipose tissue-directed FGF21 gene therapy improves metabolic and immune health in BTBR mice
Fibroblast growth factor 21 (FGF21) is a peptide hormone that serves as a potent effector of energy homeostasis. Increasingly, FGF21 is viewed as a promising therapeutic agent for type 2 diabetes, fatty liver disease, and other metabolic complications. Exogenous administration of native FGF21 peptid...
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
American Society of Gene & Cell Therapy
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7848733/ https://www.ncbi.nlm.nih.gov/pubmed/33575433 http://dx.doi.org/10.1016/j.omtm.2020.12.011 |